• LNP-mRNA Delivery of B7H3×CD3 BiTE: Potent Antitumor Efficac

  2026-08-06

  This study demonstrates that lipid nanoparticle (LNP)-mediated delivery of mRNA encoding a B7H3-redirected bispecific T cell engager (BiTE) antibody achieves high in vivo expression, prolongs serum half-life, and elicits robust antitumor responses. These findings highlight the translational promise of mRNA-based BiTE therapeutics and emphasize the importance of delivery and stabilization strategies for maximizing efficacy.

• Z-VAD-FMK: Precision Apoptosis Inhibition for Cell Death Stu

  2026-08-05

  Z-VAD-FMK (Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone) from APExBIO empowers researchers to dissect apoptosis and pyroptosis pathways with unmatched specificity. This article unpacks actionable workflows, troubleshooting tactics, and data-driven insights for maximizing success in cancer and immune cell models, drawing on the latest mechanistic advances.

• Bsa I (RNase-free): Technical Use in DNA Manipulation Workfl

  2026-08-05

  Bsa I (RNase-free) enables precise DNA cleavage in molecular biology research, particularly where the preservation of RNA integrity is essential, such as in gene cloning and DNA recombinant technology. It should not be used for diagnostic, clinical, or medical applications, and is specifically intended for workflows requiring strict RNase-free conditions.

• RIPA Lysis Buffer Strong: Optimized Protein Extraction Workf

  2026-08-04

  RIPA Lysis Buffer (Strong, without inhibitors) by APExBIO enables high-yield, customizable protein extraction from demanding cell and tissue samples, supporting advanced immunoassays. Its robust detergent formulation empowers researchers to tailor inhibitor strategies for sensitive applications such as Western blotting and kinase studies.

• Phosphatase Inhibitor Cocktail 1 (100X in DMSO): Protocol Gu

  2026-08-04

  Phosphatase Inhibitor Cocktail 1 (100X in DMSO) is designed to prevent dephosphorylation of proteins during sample preparation, ensuring accurate analysis of phosphorylation states in cell and tissue extracts. Researchers should deploy this reagent in workflows demanding preservation of labile phosphorylation, such as Western blotting or phosphoproteomics, but avoid its use in diagnostic or therapeutic settings due to its research-only designation.

• GSK343 (SKU A3449): Reliable EZH2 Inhibitor for Epigenetic A

  2026-08-03

  This article addresses critical challenges in cell-based epigenetic assays, focusing on reproducibility and data robustness when studying histone methylation. Drawing on recent research and real-world workflow hurdles, it demonstrates how GSK343 (SKU A3449) from APExBIO provides a validated, high-fidelity solution for dissecting EZH2-mediated gene regulation in cancer and stem cell models.

• Belinostat (PXD101): Scenario-Driven Solutions for Cancer As

  2026-08-03

  This article provides scenario-based, evidence-backed guidance for leveraging Belinostat (PXD101) (SKU A4096) in cell viability and proliferation assays. By addressing real-world laboratory challenges, it demonstrates how this pan-HDAC inhibitor ensures reproducible, mechanistically insightful results across cancer research workflows.

• Apigenin: Advanced HDAC Inhibition & Neuroprotection Protoco

  2026-08-02

  Apigenin (5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one) stands out for its dual utility as a potent HDAC inhibitor in cancer models and a network-validated neuroprotective agent. This guide delivers actionable experimental workflows, troubleshooting strategies, and key innovations from the latest network medicine studies that differentiate Apigenin for translational research.

• DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution:

  2026-08-01

  DAPI (4',6-Diamidino-2-Phenylindole) Nuclear Stain Solution enables rapid and reliable nuclear visualization and cell viability assessment in fixed or membrane-compromised cells. It should not be used for live-cell imaging due to its limited cell permeability. This ready-to-use reagent streamlines staining protocols for fluorescence microscopy and flow cytometry applications.

• Tiamulin (Thiamutilin): Applied Workflows in Veterinary and

  2026-07-31

  Harness the dual antibacterial and anti-inflammatory mechanisms of Tiamulin (Thiamutilin) for robust, reproducible results in both veterinary and translational lab settings. This guide breaks down not only protocol optimization but also advanced troubleshooting and cross-domain innovation, drawing on the latest integrative research.

• Pravastatin Sodium: HMG-CoA Reductase Inhibitor in Research

  2026-07-31

  Pravastatin sodium empowers researchers to precisely inhibit cholesterol biosynthesis in both cellular and animal models, with proven selectivity and robust reproducibility. Explore advanced protocols, troubleshooting insights, and comparative innovations that position this HMG-CoA reductase inhibitor as a gold standard in cardiovascular and translational studies.

• EPZ5676: DOT1L Inhibitor Workflows in MLL Leukemia Research

  2026-07-30

  EPZ5676 empowers researchers with unprecedented selectivity for DOT1L, enabling robust interrogation of H3K79 methylation and MLL fusion-driven leukemogenesis. This guide distills best-in-class workflows, troubleshooting strategies, and experimental insights for maximizing the compound’s impact in epigenetic and leukemia models.

• HDV Genotype-Specific Responses to Interferon-Alpha Therapy

  2026-07-30

  This study systematically characterizes how eight hepatitis D virus (HDV) genotypes respond to different interferon-alpha (IFN-α) subtypes. By integrating multimodal infection models, the research reveals variable antiviral efficacy influenced by HDV genotype, IFN-α subtype, and host RNA-editing factors, guiding future HDV therapeutic strategies.

• Palmitic acid (Hexadecanoic Acid): Technical Handling in Res

  2026-07-29

  Palmitic acid (SKU N2456) addresses the need for a high-purity, well-characterized saturated long-chain fatty acid for controlled studies of metabolic disorders, lipid metabolism, and protein palmitoylation. It is unsuitable for aqueous-based protocols or workflows requiring long-term solution stability, making careful preparation and solvent selection essential for reproducible results.

• ASK1 Inhibition with GS-4997 Attenuates Tubulointerstitial I

  2026-07-29

  The referenced study demonstrates that GS-4997 (Selonsertib), a selective ASK1 inhibitor, effectively halts the progression of tubulointerstitial injury in a lupus nephritis mouse model. These findings highlight a promising strategy for targeting renal inflammation and fibrosis, addressing a critical unmet need in lupus nephritis therapy.

454 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page